Found 7 matching trials
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
PHASE3Pneumonia caused by coronavirus infection COVID-19 is characterized by a co...
Location
Site 08 - "Central City Clinical Hospital of Ivano-Frankivsk City Council"
Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
PHASE2The purpose of the study is to determine if high dose Intravenous IVIG plus...
Location
Hospital Universitario Infanta Sofía
Randomised Evaluation of COVID-19 Therapy
PHASE3RECOVERY is a randomised trial of treatments to prevent death in patients h...
Location
Belgian sites are managed by the European Clinical Research Alliance on Infectious Diseases
TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19
PHASE1A Phase I/II clinical trial for safety and efficacy evaluation of treatment...
Location
Multiple Locations
SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients
PHASE1Severe and critically ill patients will be enrolled in the study (50 patien...
Location
Dow University of Health Sciences
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
PHASE3The primary objective of the Outpatient Treatment with Anti-Coronavirus Imm...
Location
Southern Arizona VA Healthcare System (074-009)
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
PHASE3This protocol will serve as a platform for assessing treatments for adult p...